Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort

Jue Liu1, Shikun Zhang2, Min Liu3

  • 1Department of Child, Adolescent and Women's Health, School of Public Health, Peking University, Beijing, China.

Insights

Maternal hepatitis B virus infection before pregnancy increases the risk of preterm and early preterm birth. Early detection and intervention are crucial for improving maternal and neonatal outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Public Health

Background:

  • Preterm birth is a leading cause of child mortality globally.
  • Maternal hepatitis B virus (HBV) infection is linked to preterm birth in developed nations.
  • Limited data exist from China and other developing countries regarding this association.

Purpose of the Study:

  • To investigate the association between pre-pregnancy hepatitis B virus infection and the risk of preterm and early preterm birth in China.
  • To provide evidence for public health strategies in regions with intermediate to high HBV prevalence.

Main Methods:

  • Population-based cohort study of 489,965 rural Chinese women with singleton livebirths (2010-2012).
  • Classification of participants into uninfected, HBsAg positive/HBeAg negative, and HBsAg positive/HBeAg positive groups.
  • Log-binomial regression used to calculate adjusted risk ratios (aRR) for preterm (<37 weeks) and early preterm (<34 weeks) birth.

Main Results:

  • Maternal pre-pregnancy HBV infection was associated with increased risk of preterm birth.
  • HBsAg positive/HBeAg negative women had a 26% higher risk of preterm birth (aRR 1.26).
  • HBsAg positive/HBeAg positive women had a 20% higher risk of preterm birth (aRR 1.20) and a 34% higher risk of early preterm birth (aRR 1.34).

Conclusions:

  • Maternal pre-pregnancy hepatitis B virus infection is an independent risk factor for preterm and early preterm birth.
  • The risk of preterm birth due to HBV infection warrants attention beyond mother-to-child transmission.
  • Comprehensive preconception screening and intervention programs for HBV are recommended to improve maternal and neonatal outcomes.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K